Avanos Medical Inc (AVNS) - Total Liabilities
Based on the latest financial reports, Avanos Medical Inc (AVNS) has total liabilities worth $268.00 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Avanos Medical Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how Avanos Medical Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Avanos Medical Inc to evaluate short-term liquidity relative to the company's equity base.
Avanos Medical Inc Competitors by Total Liabilities
The table below lists competitors of Avanos Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aurisco Pharmaceutical Co Ltd
SHG:605116
|
China | CN¥1.47 Billion |
|
Pennant Group Inc
NASDAQ:PNTG
|
USA | $567.05 Million |
|
Reit 1
TA:RIT1
|
Israel | ILA4.85 Billion |
|
Corbion NV
AS:CRBN
|
Netherlands | €674.30 Million |
|
RLJ Lodging Trust
NYSE:RLJ
|
USA | $2.59 Billion |
|
Catalyst Metals Ltd
AU:CYL
|
Australia | AU$195.72 Million |
|
NH SPAC 8
KQ:218410
|
Korea | ₩142.61 Billion |
|
Nanjing Xinjiekou Department Store Co Ltd
SHG:600682
|
China | CN¥7.08 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Avanos Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Avanos Medical Inc market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avanos Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avanos Medical Inc (2011–2025)
The table below shows the annual total liabilities of Avanos Medical Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $295.50 Million | -9.27% |
| 2024-12-31 | $325.70 Million | -28.59% |
| 2023-12-31 | $456.10 Million | -7.99% |
| 2022-12-31 | $495.70 Million | +48.86% |
| 2021-12-31 | $333.00 Million | -20.01% |
| 2020-12-31 | $416.30 Million | -22.10% |
| 2019-12-31 | $534.40 Million | -0.34% |
| 2018-12-31 | $536.20 Million | -45.31% |
| 2017-12-31 | $980.50 Million | +1.16% |
| 2016-12-31 | $969.30 Million | +2.58% |
| 2015-12-31 | $944.90 Million | -8.83% |
| 2014-12-31 | $1.04 Billion | +155.96% |
| 2013-12-31 | $404.90 Million | -15.38% |
| 2012-12-31 | $478.50 Million | -- |
| 2011-12-31 | $0.00 | -- |
About Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including… Read more